MIR4641: A Drug Target / Disease Biomarker (G100616178)

MIR4641: A Drug Target / Disease Biomarker

MIR4641, also known as interleukin-4641, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the interleukin-4 family, which is known for their role in the regulation of immune and inflammatory responses. MIR4641 has been shown to play a key role in the development and maintenance of cancer, and is Therefore, it is a potential drug target or biomarker.

MIR4641 is a 21-kDa protein that is expressed in a variety of tissues, including the liver, spleen, lung, and gastrointestinal tract. It is primarily localized to the cytoplasm of cells, and is also found in the endoplasmic reticulum (ER) and the nuclear envelope (NE). MIR4641 is a member of the interleukin-4 family, which is known for their role in the regulation of immune and inflammatory responses.

One of the key functions of MIR4641 is its role in the regulation of cell signaling pathways. MIR4641 has been shown to interact with a variety of intracellular signaling molecules, including TGF-β, NF-kappa-B, and PI3K. These interactions are involved in the regulation of cell growth, differentiation, and inflammation.

MIR4641 has also been shown to play a key role in the development and maintenance of cancer. Studies have shown that MIR4641 is overexpressed in a variety of cancer types, and that it is involved in the regulation of cellular processes that are associated with cancer progression. For example, MIR4641 has been shown to be involved in the regulation of angiogenesis, which is the process by which cancer cells develop blood vessels to supply themselves with oxygen and nutrients.

In addition to its role in cancer development, MIR4641 has also been shown to be involved in the regulation of cellular responses to infection and inflammation. For example, MIR4641 has been shown to interact with the immune protein PD-L1, and has been shown to regulate the production of pro-inflammatory cytokines.

MIR4641 is also a potential biomarker for cancer, as it has been shown to be overexpressed in a variety of cancer types. This suggests that it may be a useful target for cancer therapies. For example, MIR4641 has been shown to be targeted by a variety of small molecules, including inhibitors of tyrosine kinase activity and inhibitors of nuclear export.

In conclusion, MIR4641 is a protein that is expressed in a variety of tissues throughout the body and plays a key role in the regulation of cell signaling pathways and cancer development. Its potential as a drug target or biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of MIR4641 in cell signaling pathways and cancer development.

Protein Name: MicroRNA 4641

The "MIR4641 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4641 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746